All News

doctors.%20fellows.jpg

Gender Trends in Rheumatology

Jack Cush, MD

A study of rheumatologists in Ontario, Canada has shown an increasing percentage of women in rheumatology; unfortunately they have lower salaries but see fewer patients than do their older, male colleagues.

Read Article
RheumNow Podcast square

RheumNow Podcast - Speak Up! (6.18.2021)

Jack Cush, MD

Dr. Jack Cush talks on education, engagement and the challenge of speaking up, if not first!

Read Article
knee.surgery.jpg (keep)

Efficacy of 6 Weeks Antibiotics with Prosthetic Joint Infections

Jack Cush, MD

The NEJM has published the results of a French multicenter study showing that prosthetic joint infections can be successfully managed with 6 weeks of antibiotic therapy; this was noninferior and had better outcomes compared to 12 weeks of antibiotic therapy.

Read Article
healthcare.costs_.jpg

Congress Slams AbbVie Over Price Hikes, 'Frivolous' Patents

MedPage Today

House lawmakers on both sides of the aisle pummeled AbbVie CEO Richard Gonzalez for raising the price of two widely used drugs and for the company's "legally questionable" tactics to head off competition from biosimilars, despite pulling in healthy profits.

Read Article
TAA, TAR, Ankle, replacement

Total Ankle Arthroplasty vs. Arthodeisis?

Jack Cush, MD

 The Journal of Bone & Joint Surgery reports the findings of a 4-year trial comparing outcomes of total ankle arthroplasty (TAA) versus ankle arthrodesis (AA) in patients with severe ankle arthritis; finding that while both groups improved, TAA was associated with less pain and better function after 4 years.

Read Article
Ann Int Med: 185 Hospitalized COVID-19 pts were treated with either PBO remdesivir or HCQ. Neither remdesivir nor HCQ affected viral clearance, Sxs duration, mortality or need for mechanical ventilation. https://t.co/NEFABDD4bK

Links:

Dr. John Cush RheumNow ( View Tweet)

Pirfenidone, studied in 127 pts w/ CVD/CTD ILD, fibrotic interstitial pneumonia, chr hypersensitivity pneumonitis, & asbestoslung fibrosis. Pirefenidone had significantly less FVC% decline compared with placebo (p=0·043) https://t.co/H1s6ut4NhG

Links:

Dr. John Cush RheumNow ( View Tweet)

Rifampin is safest! 2 RCTs of 6485 latent TB pts compared 9 mos of isoniazid vs 4 mos of rifampicin. RIF had half the adverse events compared to INH; roughly half the rate of rash (1.5% v 2.7%); No grade 3-4 hepatotoxicity w/ RIF, compared 6%) w/ INH https://t.co/n1cVKyEPf6

Links:

Dr. John Cush RheumNow ( View Tweet)

These companies do auto-inflammatory gene testing in the USA. @RWCSmtg https://t.co/89bWd0SiAI
Dr. John Cush RheumNow ( View Tweet)
A study of rheumatologists in Ontario, Canada has shown an increasing percentage of women in rheumatology; unfortunately they have lower salaries but see fewer patients than do their older, male colleagues. Read more: https://t.co/JM0345p8f1 https://t.co/y95LQ6lX5i

Links:

Dr. John Cush RheumNow ( View Tweet)
Download this week’s podcast titled “Good as I Ever Was”. You can find us on SoundCloud and wherever you download your podcasts. https://t.co/hVMf8X5Dx3 https://t.co/uUDCXzO2eU

Links:

Dr. John Cush RheumNow ( View Tweet)
Ten Things to Tell Patients About Diet and Rheumatic Disease https://t.co/DpBAJwCJCY https://t.co/AVlgHfdP08

Links:

Dr. John Cush RheumNow ( View Tweet)
CDC: as of 5/15/2021; the rates of flu test positivity was 0.051-0.18% for the 2020-21 flu season - compared to usual rate of 10%-19% before COVID. Actual influenza hospitalizations dropped from 44.2 to 0.8/100 000 population https://t.co/N8b1sQWWIh

Links:

Dr. John Cush RheumNow ( View Tweet)

Italian survey foud 82% of MSK healthcare workers willing to receive COVID-19 vaccine, but only 55% of their rheumatic Dz patients were as willing, even if they perceived they were at risk. Not out of fear or distrust. more education needed https://t.co/nPhhME2dnC

Links:

Dr. John Cush RheumNow ( View Tweet)

Problems at the FDA https://t.co/mkCrYAVudo https://t.co/fAE1pNSg0q

Links:

Dr. John Cush RheumNow ( View Tweet)
Should we treat to target ourselves? Dr. David Liew ( @drdavidliew ) shares learnings from #EULAR2021. https://t.co/divGxNku6a https://t.co/UBBH0QehY1

Links:

Dr. John Cush RheumNow ( View Tweet)
WATCH: Have you heard about the advances in RA discussed at #EULAR2021? Our panel of doctors break down everything you need to know. https://t.co/C4FAQRFOhG https://t.co/tsQDW7LOFZ

Links:

Dr. John Cush RheumNow ( View Tweet)
@KDAO2011 @UpToDate @TammyTilley @ACRheum @CreakyJoints @UnaMakris @DrDavidKarp @JointMD @ejdein1 @jeffsparks @Janetbirdope @uptoTate @RichardPAConway @MeralElRamahiMD @Yuz6Yusof @AurelieRheumo @Stiddyo @doctorRBC @RheumNow also, and I still remember this from the very first time I met him in person: "Do you know what the most important thing to remember is?" (nervous pause from me) "Have fun. You've gotta have fun!" I still live by this...

David Liew drdavidliew ( View Tweet)

A giant in our field. He has been my teacher for most of my career (since fellowship). He taught me how to care for patients, conduct research, & teach. My favorite quote is "If you're doing nothing, you're not doing anybody any good!" What is something he taught you? @rheumnow https://t.co/Fyw1u8wln8

Links:

k dao KDAO2011 ( View Tweet)

Curious to find out the answer?https://t.co/cXjUeQAwHD #EULAR2021 @RheumNow #OP0012 https://t.co/7q5yZLD96v

Links:

Aurelie Najm AurelieRheumo ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×